S Hassid

CHU Dinant Godinne UCL Namur

Papers

2

Total Citations

23

H-Index

2

About

Dr. S. Hassid is a pioneering head and neck surgeon whose research focuses on minimally invasive oncologic surgery and organ-preserving treatments for laryngeal and pharyngeal cancers. Dr. Hassid’s major contributions include the development and validation of transoral robotic surgery hypopharyngectomy (TORSH), a groundbreaking technique that offers patients with hypopharyngeal tumors a less morbid alternative to traditional open surgery. The seminal 2020 feasibility and outcomes study on TORSH, which has garnered 16 citations, established the safety and efficacy of this robotic approach, demonstrating reduced hospital stays and improved functional recovery. More recently, Dr. Hassid is leading the SUPRA-QoL trial (2023, 7 citations), an ambitious prospective observational study evaluating the oncological, functional, and quality-of-life outcomes of advanced technologies—including transoral robotic surgery and radiotherapy—in treating supraglottic squamous cell carcinoma. This work directly addresses the critical need for evidence-based comparisons of modern organ-sparing techniques against traditional total laryngectomy. With a growing citation impact, Dr. Hassid is recognized as a key innovator in head and neck oncology, advancing the frontier of function-preserving cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
23
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Transoral robotic surgery hypopharyngectomy (TORSH): feasibility and outcomes
16 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: CHU Dinant Godinne UCL Namur

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago